| NCT07299734 | Feasibility and Safety of a Combined Augmented Reality and Functional Electrical Stimulation System | University Health Network, Toronto | | - Age 18 - 65 yrs
- Level C1-T1
AIS A, B, C, D- All
| Recruiting | 7 | EARLY_PHASE1 | Technology | General health | - Adverse Events (AEs)
- Feasibility
| 14 weeks | 01 January 2026 | 23 December 2025 | 1 | |
| NCT07361627 | Upper Limb Rehabilitation Using Non-invasive Spinal Cord Stimulation | Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal | | - Age ≥ 16 yrs
- Level C1-T1
AIS A, B, C, D- ≤ 6 months
- NOT have a pacemaker
| Recruiting soon | 40 | NA | Technology | Arm/hand function | - Grasp and Release Test (GRT)
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Motor Evoked Potentials (MEPs)
- Sensory evoked potentials (including mixed and dermatomal, mSSEPs, dSSEPs, contact heat/laser evoked potentials- CHEPS/LEPs)
| 12 weeks | 01 April 2026 | 23 January 2026 | 1 | |
| NCT07334977 | Synergistic Effect of Non-invasive Brain and Spinal Cord Stimulation | Centre National de la Recherche Scientifique, France | | - Age ≥ 18 yrs
- Level C1-T1
AIS A, B, C, D- All
- NOT have implanted medical devices (cardiac valve, endovascular devices, ventricular shunt valve, surgical clips, metallic sutures, staples, stent, osteosynthesis or arthrodesis hardware)
| Recruiting | 45 | PHASE2 | Technology | Arm/hand function | - Feasibility
- Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
- Surface Electromyography (sEMG)
| 25 days | 11 December 2024 | 12 January 2026 | 2 | |
| NCT07369349 | Artificial Int: Neurogenic Bowel Education in Spinal Cord Injury Patients | Saglik Bilimleri Universitesi | | - Age 18 - 65 yrs
- Level C1-S5
AIS - All
| Recruiting soon | 34 | NA | Psychosocial/other | Bowel health | - Neurogenic Bowel Dysfunction Score (NBD or NBDS)
| 12 weeks | 20 February 2026 | 27 January 2026 | 0 | |
| NCT07303582 | Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities | Oxford University Hospitals NHS Trust | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
| Recruiting | 50 | PHASE4 | Drug | Pain | - Ashworth and Modified Ashworth Scale (MAS)
- Barthel Index (BI)
- European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L)
- Goal Attainment Scaling (GAS) score
- Neuropathoc Pain Symptom Inventory (NPSI)
- Surface Electromyography (sEMG)
| 24 weeks | 02 December 2025 | 26 December 2025 | 1 | |
| NCT07251491 | Psilocybin to Treat Depression in Spinal Cord Injury | James J. Peters Veterans Affairs Medical Center | | - Age ≥ 22 yrs
- Level C1-S5
AIS - ≥ 12 months
- have a confirmed diagnosis of depression
| Recruiting soon | 30 | PHASE1, PHASE2 | Drug | Mental health and psychosocial factors | - Adverse Events (AEs)
- Beck Depression Inventory (BDI)
| 13 months | 01 January 2026 | 26 November 2025 | 1 | |
